BioCentury
ARTICLE | Company News

Galapagos, Servier deal

March 12, 2012 7:00 AM UTC

Galapagos received €3.5 million ($4.6 million) in milestone payments from Servier under a 2010 deal to discover and develop small molecules against undisclosed targets for osteoarthritis (OA). The pay...